Qube Research & Technologies (QRT)’s Crescent Capital BDC CCAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-13,727
Closed -$194K 3600
2025
Q2
$194K Sell
13,727
-22,099
-62% -$339K ﹤0.01% 2915
2025
Q1
$613K Buy
35,826
+19,736
+123% +$367K ﹤0.01% 2469
2024
Q4
$309K Sell
16,090
-9,944
-38% -$188K ﹤0.01% 2704
2024
Q3
$482K Sell
26,034
-13,650
-34% -$253K ﹤0.01% 2286
2024
Q2
$745K Buy
39,684
+15,089
+61% +$269K ﹤0.01% 2005
2024
Q1
$425K Buy
24,595
+9,640
+64% +$162K ﹤0.01% 2625
2023
Q4
$260K Buy
14,955
+6,625
+80% +$110K ﹤0.01% 2661
2023
Q3
$142K Buy
+8,330
New +$138K ﹤0.01% 2536

Other funds holding CCAP

Qube Research & Technologies (QRT)'s CCAP Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of Crescent Capital BDC (CCAP) in Q3 2025, closing a stake of 13,727 shares — an estimated $194K sold.

Qube Research & Technologies (QRT) first reported a position in CCAP in Q3 2023 and held it in 8 quarters. The position peaked at $745K in Q2 2024. 93 funds tracked by Wall St. Rank hold CCAP as of Q3 2025.

  • Qube Research & Technologies (QRT) reported no remaining Crescent Capital BDC position as of Q3 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 13,727 Crescent Capital BDC shares in Q3 2025, an estimated $194K.
  • Qube Research & Technologies (QRT) first reported a position in Crescent Capital BDC in Q3 2023 and held it in 8 quarters.
  • Qube Research & Technologies (QRT)'s Crescent Capital BDC position peaked at $745K in Q2 2024.
  • 93 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.